Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.

MLA

Zhang, Chi, et al. “Efficacy and Safety of Anluohuaxian in the Treatment of Patients with Severe Coronavirus Disease 2019- a Multicenter, Open Label, Randomized Controlled Study: A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials, vol. 21, no. 1, June 2020, pp. 1–3. EBSCOhost, https://doi.org/10.1186/s13063-020-04399-8.

APA

Zhang, C., Li, J., Wu, Z., Wang, H., Que, C., Zhao, H., & Wang, G. (2020). Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial. Trials, 21(1), 1–3. https://doi.org/10.1186/s13063-020-04399-8

Chicago

Zhang, Chi, Jiawen Li, Zhao Wu, He Wang, Chengli Que, Hong Zhao, and Guiqiang Wang. 2020. “Efficacy and Safety of Anluohuaxian in the Treatment of Patients with Severe Coronavirus Disease 2019- a Multicenter, Open Label, Randomized Controlled Study: A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials 21 (1): 1–3. doi:10.1186/s13063-020-04399-8.